Daiichi Sankyo
Clinical trials sponsored by Daiichi Sankyo, explained in plain language.
-
Three-Drug combo aims to shrink dangerous heart plaque before it causes a crisis
Disease control Not yet recruitingThis study aims to see if a combination of three cholesterol-lowering drugs can shrink and stabilize fatty plaque buildup in the heart's arteries. It will enroll about 103 adults who have this plaque but have not yet had a heart attack or stroke. Researchers will use special hear…
Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Doctors track cholesterol drugs in everyday patients
Disease control Not yet recruitingThis study aims to understand the real-world benefits and side effects of two cholesterol-lowering drugs, bempedoic acid and a combination pill with ezetimibe. It will observe about 2,560 adult patients with high cholesterol in Asia and Latin America during their regular doctor v…
Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC